Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    y-55-52120-140
Show Display Options
Rank Status Study
1 Completed Dysport® Adult Lower Limb Spasticity Study
Condition: Leg Spasticity
Interventions: Drug: Botulinum type A toxin (Dysport®);   Drug: Placebo

Indicates status has not been verified in more than two years